Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma
Background Systemic chemotherapy or chemoradiation therapy has proven to be effective in treating advanced biliary tract carcinoma (BTC). However, its efficacy in the adjuvant setting remains controversial. Therefore, this study aimed to determine the prognostic significance of genomic biomarkers in...
Main Authors: | Yunfeng Li, Chaochao Tan, Xinmin Yin, Siwei Zhu, Rongyao Cai, Chunhong Liao, Yifei Wu, Qihong Zeng, Chengzhi Cai, Wang Xie, Xiangyu He, Hao‐quan Wen, Guomin Lin, Qingqing He, Tingting He, Peng Gu, Chang‐jun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6261 |
Similar Items
-
Microbiome and Biliary Tract Cancer
by: Jin-Seok Park
Published: (2024-01-01) -
Claudins: from gatekeepers of epithelial integrity to potential targets in hepato-pancreato-biliary cancers
by: Hyein Jeon, et al.
Published: (2024-09-01) -
Cholangiocarcinoma: Current Knowledge and New Developments
by: Boris Blechacz
Published: (2017-01-01) -
Outcome of patients with perihilar cholangiocarcinoma and previous biliary instrumentation: an observational study
by: Karen T. Brown, et al.
Published: (2024-05-01) -
Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018–2023
by: Donghee Kim, et al.
Published: (2024-10-01)